News & Articles
Selected Filters:
Imperial to begin first human trials of new COVID-19 vaccine
Clinical researchers are this week set to begin human trials of a new coronavirus vaccine developed by researchers at Imperial College London
Adjuvants to enhance cellular immune response to vaccines
Increase the effectiveness of human vaccines against infectious diseases such as COVID-19
CAR-T cells as a model for clinical development and commercialization
Join this expert webinar to discover the complexities and challenges for wide patient access to new chimeric antigen receptor T (CAR-T) cell therapies
Promega announces CE marking for OncoMate MSI Dx Analysis System
New diagnostic test for MSI in solid tumors can inform physicians on immuno-oncology therapies and can guide treatment decisions for patients with Lynch-associated cancers
AstraZeneca to supply Europe with up to 400 million doses of Oxford University’s COVID-19 vaccine
Company exploring further additional global capacity to provide broad and equitable access
PerkinElmer launches pre-eclampsia kit for enhanced management
New kit is designed to enable short term prediction of pre-eclampsia and aid in diagnosis in the second and third trimesters of pregnancy
Proteomics on NGS: Game-changing technology to increase multiplexing and throughput
Join us on Monday, June 22, to learn how Olink’s latest immunoassay technology is taking proteomics to a new level
How to Buy Clinical Automation Technology eBook: 2020 edition
Your guide to choosing and implementing the best automated solutions for the clinical laboratory
EKF opens for live chats at ENDO Online 2020
Diagnostics for glycemic monitoring and ketosis testing on show
Fluxion Biosciences joins BloodPAC consortium to accelerate liquid biopsy development
Participation will help advance liquid biopsy adoption by collaborating among key industry stakeholders
FDA authorizes first COVID-19 diagnostic test utilizing next generation sequence technology
llumina's COVIDSeq aims to generate information about the genomic sequence of the virus
Sherlock Biosciences, IDT collaborate to manufacture CRISPR-based SARS-CoV-2 testing kits
Large-scale manufacturing of rapid diagnostic test kit and reagents to enable increased testing capacity for COVID-19 worldwide
Vote for Best New Clinical Laboratory Product of 2019 in the Scientists’ Choice Awards
To be in with a chance of winning a $500 Amazon Gift Card, simply cast your vote for the product that has made the most difference to your work
How mass cytometry is driving COVID-19 research: Your questions answered
Watch this on-demand webinar to discover how mass cytometry can be used to monitor immune responses to new therapeutics
Biolog-id joins forces with LifeShare Blood Center to combat COVID-19
LifeShare Blood Center deploys Biolog-id’s cutting-edge technology providing digital visibility to convalescent plasma containing antibodies from recovered COVID-19 patients
Ziath introduces optimized packages for tracking COVID-19 patient samples
This aims to assist labs involved with the essential RT-PCR assay part of the “test, trace and isolate” strategy
Avacta provides update on COVID-19 antigen diagnostic test development with Adeptrix
Highly specific prototype test detects the virus spike protein at clinically relevant concentrations
Join the SelectScience webinar series on drug discovery and complex biology
Our expert webinar series aims to help you get the most from your drug discovery research
Siemens Healthineers receives FDA emergency use authorization for SARS-CoV-2 total antibody test
Total antibody test aims to deliver superior clinical performance with 100% sensitivity and 99.8% specificity